Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.

PloS one | 2019

Fibroblast growth factor 23 is an emerging vascular biomarker, recently associated with cerebral small vessel disease and poor cognition in patients on dialysis. It also interacts with klotho, an anti-aging and cognition enhancing protein.

Pubmed ID: 30830941 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: UH3 NS100605
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS017950
  • Agency: NIA NIH HHS, United States
    Id: R01 AG054076
  • Agency: NIA NIH HHS, United States
    Id: RF1 AG059421
  • Agency: NIA NIH HHS, United States
    Id: R01 AG049607
  • Agency: NIA NIH HHS, United States
    Id: U01 AG049505
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201500001I
  • Agency: NHLBI NIH HHS, United States
    Id: N01 HC025195
  • Agency: NIA NIH HHS, United States
    Id: P30 AG010129
  • Agency: NIA NIH HHS, United States
    Id: R01 AG033193
  • Agency: NINDS NIH HHS, United States
    Id: UH2 NS100605
  • Agency: NIA NIH HHS, United States
    Id: U01 AG052409
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL060040
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL070100

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) (tool)

RRID:SCR_013142

Repository that serves to coordinate searches across data and biospecimen collections from participants in numerous clinical trials and epidemiologic studies and to provide an electronic means for requests for additional information and the submission of requests for collections. The collections, comprising data from more than 80 trials or studies and millions of biospecimens, are available to qualified investigators under specific terms and conditions consistent with the informed consents provided by the individual study participants. Some datasets are presented with studies and supporting materials to facilitate their use in reuse and teaching. Datasets support basic research, clinical studies, observational studies, and demonstrations. Researchers wishing to apply to submit biospecimen collections to the NHLBI Biorepository for sharing with qualified investigators may also use this website to initiate that process.

View all literature mentions